Literature DB >> 2209656

European multi-centre comparison of thallium 201 and technetium 99m methoxyisobutylisonitrile in ischaemic heart disease.

M N Maisey1, A Lowry, A Bischof-Delaloye, R Fridrich, E Inglese, M N Khalil, J B van der Schoot.   

Abstract

Fifty-six patients in Europe were entered into a multi-centre study to compare the accuracy of technetium 99m methoxyisobutylisonitrile (99mTc-MIBI) for the detection of coronary artery disease (CAD) with thallium 201 (201Tl) chloride perfusion scanning. The results showed a high degree of concordance between the two radiopharmaceuticals. Some 81% (678/840) of myocardial segments showed the same result (normal, infarct or ischaemia), and 80% (45/56) of patients had the same diagnosis. Overall detection of CAD in patients was 98% for 201T1 and 96% for 99mTc-MIBI. Detection of CAD in total arteries was 68% for both agents. In this study 99mTc-MIBI was as accurate as 201Tl for the detection of coronary artery stenoses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209656     DOI: 10.1007/bf01280254

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  10 in total

1.  Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease.

Authors:  J K Kahn; I McGhie; M S Akers; M N Sills; T L Faber; P V Kulkarni; J T Willerson; J R Corbett
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

2.  Same day injections of Tc-99m methoxy isobutyl isonitrile (hexamibi) for myocardial tomographic imaging: comparison between rest-stress and stress-rest injection sequences.

Authors:  R Taillefer; A Gagnon; L Laflamme; J Grégoire; J Léveillé; D C Phaneuf
Journal:  Eur J Nucl Med       Date:  1989

3.  The localization of myocardial ischaemia with technetium-99m methoxy isobutyl isonitrile and single photon emission computed tomography.

Authors:  D J West; Y C Najm; R Mistry; S E Clarke; I Fogelman; M N Maisey
Journal:  Br J Radiol       Date:  1989-04       Impact factor: 3.039

4.  Quantitative planar imaging with technetium-99m methoxyisobutyl isonitrile: comparison of uptake patterns with thallium-201.

Authors:  A J Sinusas; G A Beller; W H Smith; E L Vinson; V Brookeman; D D Watson
Journal:  J Nucl Med       Date:  1989-09       Impact factor: 10.057

5.  The contraction fraction (CF) in myocardial studies with technetium-99m-isonitrile (MIBI)--correlations with radionuclide ventriculography and infarct size measured by SPECT.

Authors:  M Clausen; E Henze; A Schmidt; R Weller; R Lietzenmayer; D Hellwig; F Bitter; P Hildebrand; V Hombach; W E Adam
Journal:  Eur J Nucl Med       Date:  1989

6.  Methoxyisobutylisonitrile (MIBI) Tc 99m SPECT to establish a correlate to coronary flow reserve, the perfusion reserve, from global and regional myocardial uptake after exercise and rest.

Authors:  U Buell; H J Kaiser; F Dupont; R Uebis; E Kleinhans; P Hanrath
Journal:  Eur J Nucl Med       Date:  1990

7.  Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods.

Authors:  H Kiat; J Maddahi; L T Roy; K Van Train; J Friedman; K Resser; D S Berman
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

8.  The evaluation of ventricular function using gated myocardial imaging with Tc-99m MIBI.

Authors:  Y C Najm; A D Timmis; M N Maisey; S V Ellam; R Mistry; P V Curry; E Sowton
Journal:  Eur Heart J       Date:  1989-02       Impact factor: 29.983

9.  Clinical comparison between thallium-201 and Tc-99m-methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease.

Authors:  R Taillefer; R Lambert; G Dupras; J Grégoire; J Léveillé; R Essiambre; D C Phaneuf
Journal:  Eur J Nucl Med       Date:  1989

10.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

  10 in total
  7 in total

1.  Exercise gated planar myocardial perfusion imaging using technetium-99m sestamibi for the diagnosis of coronary artery disease: an alternative to exercise tomographic imaging.

Authors:  F Jamar; R Topcuoglu; F Cauwe; P De Coster; V Roelants; C Beckers; W Wijns; J A Melin
Journal:  Eur J Nucl Med       Date:  1995-01

Review 2.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

3.  Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium 99m tetrofosmin.

Authors:  N Takahashi; N Tamaki; E Tadamura; M Kawamoto; T Torizuka; Y Yonekura; K Okuda; R Nohara; S Sasayama; J Konishi
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

4.  Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events.

Authors:  D D Miller; H G Stratmann; L Shaw; B R Tamesis; M D Wittry; L T Younis; B R Chaitman
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

5.  A comparative evaluation of Tl-201 and Tc-99m sestamibi myocardial perfusion spect imaging in diabetic patients.

Authors:  Ozgür Omür; Zehra Ozcan; Murat Argon; Ebru Tani Acar
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-19       Impact factor: 2.357

6.  Evaluation of changes in myocardial perfusion and function on exercise in patients with coronary artery disease by gated MIBI scintigraphy.

Authors:  P Avery; N Hudson; P Hubner
Journal:  Br Heart J       Date:  1993-07

7.  A miniaturized rapid paper chromatographic procedure for quality control of technetium-99m sestamibi.

Authors:  M Patel; S Sadek; S Jahan; A Owunwanne
Journal:  Eur J Nucl Med       Date:  1995-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.